TITLE

Opponents of stem-cell patent win restrictions

AUTHOR(S)
Abbott, Alison; Schmidt, Oliver
PUB. DATE
August 2002
SOURCE
Nature;8/1/2002, Vol. 418 Issue 6897, p470
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the restriction in the scope of patent covering technologies for purifying human and animal embryonic stem cells by the European Patent Office in 2002. Details of the patent coverage; Groups that filed objections to the patent; Claim against the methods involved in the patent; Basis for the patent restriction.
ACCESSION #
7208049

 

Related Articles

  • THE MORPHING PATENT PROBLEM. Shulman, Seth // Technology Review;Nov2001, Vol. 104 Issue 9, p33 

    Focuses on the human embryonic stem cell research in the United States. Blame on the federal government for the funding of stem cell research; Role of the Wisconsin Alumni Research Foundation; Clarity on the problem of broad patents in embryonic technology.

  • Patent Office upholds Geron's embryonic stem cell patent.  // Medical Device Daily;2/29/2008, Vol. 12 Issue 41, p10 

    The article reports on the decision of the U.S. Patent and Trademark Office to uphold the validity of a key patent for human embryonic stem cells. The patent is assigned to the Wisconsin Alumni Foundation. To announce its decision, the agency issued an Action Closing Prosecution in the...

  • Analyzing the broadening scope of patentability in the advancing field of biotechnology. Downing, Jessica // Journal of Commercial Biotechnology;Sep2012, Vol. 18 Issue 4, p27 

    The current U.S. patent system is considered to provide the broadest patent protection of all patent systems in existence, especially with respect to the biotechnology industry. Advances in science and technology have been key contributors to the growth and development of legislation controlling...

  • News In Brief.  // Nature Biotechnology;Jul2005, Vol. 23 Issue 7, p771 

    The article presents information related to biotechnology industries. Days after the European Patent Office announced the shelving of patent applications for embryonic stem (ES) cells until the European Union agrees upon an ethical framework, the trend toward relaxation of national laws on...

  • European Stem Cell Foes Rejoice at WARF Ruling. O'Donnell, Peter // BioWorld International;12/3/2008, Vol. 13 Issue 49, p3 

    The article reports on the reaction by European critics of embryonic stem cell research to the rejection by the European Patent Office of the so-called Wisconsin Alumni Research Foundation (WARF) patent on stem cells. According to Peter Liese, a German member of the European Parliament, this is...

  • Embryonic stem cells: the moral dilemma of patentability and funding. San Martín, Beatriz // Pharmaceutical Technology Europe;Sep2009, Vol. 21 Issue 9, p50 

    The article discusses the increasing moral debate concerning the patentability and finance of human embryonic stem cells (hES) development in Europe. The author asserts that hES cell research has gained wide interest from scientist because it contains since it allows them to gain better...

  • Patent Impasse Hampering Stem Cell Research in EU. Sheridan, Cormac // BioWorld International;6/30/2010, Vol. 15 Issue 26, p5 

    The article reports on the statement issued by Outi Hovatta of the Karolinska Institute of Stockholm, Sweden who noted the patent-related challenge faced by stem cell research in the European Union. According to her, research on innovations based on human embryonic stem cell (hESC) in Europe are...

  • BRUSTLE V GREENPEACE, EMBRYONIC STEM CELL RESEARCH AND THE EUROPEAN COURT OF JUSTICE'S NEW FOUND MORALITY. Staunton, Ciara // Medical Law Review;Jun2013, Vol. 21 Issue 2, p310 

    The article discusses the case Brustle v. Greenpeace which was concerning a referral from the Federal Court of Justice of Germany to the European Court of Justice (ECJ) for interpreting issues under the Biotechnology Directive which provides legal protection for biotechnology inventions. It...

  • Stem Cells Industry and Beyond: What is the Aftermath of Brüstle? Bonadio, Enrico // European Journal of Risk Regulation;2012, Vol. 3 Issue 1, p93 

    The article reports that the Court of Justice of the European Union (CJEU) released its decision in Brüstle v Greenpeace case. This is a widely reported case on the exclusion from patentability of inventions related to human embryonic stem cells (HESCs) on morality grounds. The article...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics